摘要
目的:分析急性肺栓塞患者治疗中应用利伐沙班抗凝的疗效。方法:2018年1月-2019年1月收治急性肺栓塞患者78例,随机分为两组,各39例。观察组应用利伐沙班行抗凝治疗;对照组应用华法林行抗凝治疗。比较两组治疗效果。结果:观察组总有效率高于对照组,差异有统计学意义(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:急性肺栓塞患者抗凝治疗中应用利伐沙班可取得显著疗效,同时安全性良好。
Objective:To analyze the anticoagulant effect of rivashaban in the treatment of acute pulmonary embolism.Methods:From January 2018 to January 2019,78 patients with acute pulmonary embolism were enrolled,and they were randomly divided into two groups with 39 patients in each group.The observation group was treated with rivasaban anticoagulant and the control group was treated with warfarin anticoagulant therapy.The therapeutic effect between groups was compared.Results:The total effective rate of the observation group was higher than the control group,and the difference was statistically significant(P<0.05).The incidence of adverse reactions between groups was compared,and the difference was not statistically significant(P>0.05).Conclusion:The application of rivaroxaban in anticoagulant therapy for acute pulmonary embolism can be effective,at the same time,the security is good.
作者
段伟
Duan Wei(Department of Respiratory Medicine,the Central Hospital of Jilin City,Jilin Province,Jilin Jilin 132011)
出处
《中国社区医师》
2020年第2期14-15,共2页
Chinese Community Doctors
关键词
急性肺栓塞
利伐沙班
抗凝
Acute pulmonary embolism
Rivashaban
anticoagulant
